Mental disorders, functional impairment, and nerve growth factor.

Area of Science:

• Neuroscience
• Psychiatry
• Biochemistry

Background:

• Nerve Growth Factor (NGF), a neurotrophin, is implicated in psychiatric disorders.
• Functionality, encompassing daily activities and social participation, is crucial for assessing living conditions in psychiatric patients.
• Limited research exists on functionality in various mental disorders and its biological underpinnings, particularly NGF's role.

Purpose of the Study:

• To investigate serum NGF levels in psychiatric patients.
• To determine the association between serum NGF levels and patient functionality.

Main Methods:

• A cross-sectional study involving 286 psychiatric patients from a public mental health service in Brazil.
• Data collection included sociodemographic information, Mini International Neuropsychiatric Interview (M.I.N.I) for diagnosis, and Functioning Assessment Short Test.
• Serum NGF levels were quantified using enzyme-linked immunosorbent assay (ELISA).

Main Results:

• Significantly increased serum NGF levels were observed in patients with obsessive-compulsive disorder (OCD) and generalized anxiety disorder (GAD) compared to controls.
• NGF levels showed a negative association with autonomy, work, and cognitive functioning.
• These findings suggest a link between altered NGF levels and impaired functionality in mental disorders.

Conclusions:

• Elevated serum NGF levels are associated with specific psychiatric conditions like OCD and GAD.
• Serum NGF levels are negatively correlated with key aspects of functionality, including autonomy, work, and cognition.
• This study highlights the potential of NGF as a biomarker for functional impairment in mental disorders.